The DOJ's declination to intervene is a significant de-risking event for Corcept, removing the most severe financial threat from this qui tam action. Monitor for any future developments in the relator's amended complaint, but the absence of government backing substantially weakens the plaintiff's case. The stock may re-rate higher as this overhang lifts.
Price Chart
Executive Summary
Corcept disclosed that the DOJ, California Department of Insurance, and named Plaintiff States have all declined to intervene in a qui tam lawsuit filed by a former employee in February 2017 regarding the sale and promotion of Korlym. The relator served an amended complaint on June 2, 2026, and the company intends to vigorously defend. This removes the risk of government-backed prosecution, significantly reducing the potential liability exposure.
Key Facts
- DOJ, California Department of Insurance, and named Plaintiff States declined to intervene in qui tam action
- Lawsuit initiated February 2017 by former employee (Relator Stephen Elliott)
- DOJ had issued a subpoena in November 2021; company responded in full
- Relator served amended complaint on June 2, 2026
- Company intends to vigorously defend against all claims
Financial Impact
No specific financial exposure disclosed; DOJ declination removes government-backed treble damages risk, which could have been material relative to $7.6B market cap
Risk Factors
- Relator may still pursue the case independently without government support
- Amended complaint could introduce new allegations or theories of liability
- Discovery costs and management distraction from ongoing litigation
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-254622 |
| Document: 0001193125-26-254622-index-headers.html | 0001193125-26-254622 |
| Document: 0001193125-26-254622-index.html | 0001193125-26-254622 |
| Document: 0001193125-26-254622.txt | 0001193125-26-254622 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 28, 2026 5w ago | Insider Cluster | $113.88 $115.63 | ▲ +1.54% | ▲ +1.28% | $116.49 (+2.29%) |
Aug 28, 2026 5w ago | Insider Cluster | $113.88 $116.10 | ▲ +1.95% | ▲ +1.44% | $116.49 (+2.29%) |
Aug 27, 2026 5w ago | Insider Cluster | $116.93 $117.00 | ▲ +0.06% | ▲ +0.16% | $116.49 (−0.38%) |
Aug 20, 2026 6w ago | Insider Cluster | $121.05 $114.86 | ▼ −5.11% | ▼ −5.11% | $116.49 (−3.77%) |
Aug 18, 2026 6w ago | Insider Cluster | $118.10 $111.85 | ▲ +5.29% | ▲ +4.30% | $116.49 (+1.36%) |
Aug 12, 2026 7w ago | Insider Cluster | $112.18 $114.92 | ▲ +2.44% | ▲ +4.34% | $116.49 (+3.84%) |
Aug 12, 2026 7w ago | Insider Cluster | $112.18 $114.92 | ▲ +2.44% | ▲ +4.34% | $116.49 (+3.84%) |
Aug 6, 2026 8w ago | Insider Cluster | $110.77 $111.62 | ▲ +0.77% | ▲ +1.16% | $116.49 (+5.16%) |
Aug 5, 2026 8w ago | Insider Cluster | $107.95 $112.80 | ▲ +4.49% | ▲ +3.89% | $116.49 (+7.91%) |
Jul 23, 2026 10w ago | Court Ruling | $96.66 $121.05 | ▲ +25.23% | ▲ +21.92% | $116.49 (+20.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access